Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17159580 | 1.00 | MAPT (0.36) | MAPTCYP2C19CYP3A4CYP2C9RCE1 | |
| SCHEMBL17159578 | 1.00 | MAPT (0.36) | MAPTCYP2C19CYP3A4CYP2C9RCE1 | |
| SCHEMBL17159642 | 0.88 | MAPT (0.36) | MAPTCYP2C19CYP3A4CYP2C9RCE1 | |
| SCHEMBL15652722 | 0.88 | MAPT (0.36) | MAPTCYP2C19CYP3A4CYP2C9RCE1 | |
| SCHEMBL17159638 | 0.88 | MAPT (0.36) | MAPTCYP2C19CYP3A4CYP2C9RCE1 | |
| SCHEMBL13207896 | 0.82 | MAPT (0.36) | MAPTCYP2C19CYP3A4CYP2C9RCE1 | |
| SCHEMBL17170454 | 0.80 | MAPT (0.36) | MAPTCYP2C19CYP3A4CYP2C9RCE1 | |
| SCHEMBL17159599 | 0.79 | MAPT (0.36) | MAPT | |
| SCHEMBL15653507 | 0.79 | MAPT (0.36) | MAPT | |
| SCHEMBL15654639 | 0.79 | MAPT (0.36) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9975911-B2 | Antibacterial compounds and biological applications thereof | MUTABILIS (FR) | 2018-05-22 | — | — | US | disclosed |
| EP-2912043-B1 | NEW ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF | MUTABILIS (FR) | 2016-11-30 | — | — | EP | disclosed |
| US-20150291636-A1 | ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF | LABORATOIRE BIODIM (FR) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291636-A1 | ANTIBACTERIAL COMPOUNDS AND BIOLOGICAL APPLICATIONS THEREOF | C3AR1, CFH, MSR1 | MAPT 4880/4885CYP2C19 4557/4885CYP3A4 3271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.